-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*For medical professionals only
Alzheimer's disease is not an inevitable occurrence of human aging, it is a disease.
As the average human lifespan increases, Alzheimer's disease (AD) is becoming more common
.
Although unlike other diseases, patients will feel obvious physiological pain, but it will gradually take away the patient's memory, cognition, social skills, self-care ability and even self-esteem.
.
.
.
AD can cause cognitive impairment preceded by forgetting, but it does not mean that poor memory necessarily has AD
.
What are the clinical manifestations of AD? What are the key points of diagnosis? Then look
down.
One
The clinical manifestations should be distinguished
- Mainly cognitive impairment, mental and behavioral abnormalities, and decreased social life functioning
.
- Changes in life functioning: early manifestations are mainly manifested as near memory decline
.
As the disease progresses, the signs of impairment become more apparent
.
Terminally ill patients need to be completely cared for
by others in all aspects of their lives. - Mental and behavioral symptoms: Mental and behavioral changes will occur in the early stage, such as lack of initiative, reduced activity, loneliness, selfishness, reduced interest in the surrounding environment, more cold to the people around them, even indifference to relatives, emotional instability, irritability
.
Further damage will worsen psychobehavioral symptoms, and fragmentary hallucinations and delusions (mostly theft and jealousy) may occur; roaming or going out without purpose; Sleep rhythm disorder, some patients will have day and night reversal; Picking up collected scraps; may manifest as hyperactive instincts, such as decompression and overeating; Sometimes agitated and even aggressive behavior
can occur.
- Cognitive impairment: preceded by forgetting, it will subsequently affect almost all cognitive domains, including computing, orientation, visuospace, executive function, comprehension generalization, etc.
, and aphasia, agnosia, and apraxia
will also occur.
Two
What are the key points of diagnosis?
- insidious onset, progressive aggravation, impairment of work and daily life functions;
- cognitive impairment mainly amnesia, as well as progressive impairment of non-amnesic domains such as language function, visual space, executive function, etc.
;
- Abnormal changes
in personality, mental activity, and behavior.
- Other common neurological and psychiatric disorders in old age, such as delirium, senile depressive disorder, senile psychosis, central nervous system infection and inflammation, vascular cognitive impairment, and degenerative diseases such as Lewy body dementia and frontotemporal dementia are excluded
.
Three
What are the auxiliary inspection methods?
- Complete physical examination, including neurological
.
- Psychiatric examination
.
- Cognitive Assessment Cognitive Function Screening (Simplified Intelligent Mental State Test Scale or Montreal Cognitive Assessment Scale), Life Ability Assessment, Dementia Severity Assessment, Overall Assessment of Cognitive Function, and Assessments Specific to a Specific Cognitive Dimension such as Memory Assessment (Hopkins Word Learning Test Revised Edition), Language Proficiency Assessment (Boston Named Test), Attention/Working Memory Assessment (Digital Breadth Test), Vivisuospatial Aptitude Assessment (Clock Drawing Test), Executive Function Assessment (Wired Test), etc
。
- Laboratory tests: in addition to routine biochemical items (which should include homocysteine), the focus should be on excluding thyroid dysfunction, vitamin B12 and folate deficiency, anemia, neurosyphilis and other medical disorders
that may affect cognitive function.
- EEG: used to exclude Creutz-Jakoh disease, etc
.
- Brain imaging: Magnetic resonance imaging (including hippocampus) is recommended to exclude cerebrovascular disease and clarify the degree of cerebral atrophy, and fluorodeoxyglucose-positron emission tomography can also be considered to reflect the metabolic level
of different parts of the brain.
- Alzheimer's disease biomarkers: positron emission tomography scan showing positive β amyloid or Tau imaging
.
- Genetic testing: may be tested
for genetic mutations.
For more drug treatment methods, please consult [Clinical Decision App]Open
the Clinical Decision Assistant AppClinical Guidelines Module DialogueFree Guide1.
Scan 👇
the QR code below 2.
Download the Clinical Decision Assistant App 3.
Open the Decision Assistant App
and click the icon
4.
Search for the guide you want to see
Download the app and learn a new guide every day!
Download the decision assistant App, the guide is free at any time ~References: [1] Diagnosis and treatment norms for Alzheimer's disease (2020 edition)
▼▼▼ Click to read the original article You can also download the app